Abstract:Background: Inflammation might play a critical role in the pathogenesis and progression of Philadelphia-negative myeloproliferative neoplasms (Ph − MPNs) with elevated inflammatory cytokines in peripheral blood (PB). However, the inflammatory status inside the bone marrow (BM), which is the place of malignancy origin and important microenvironment of neoplasm evolution, has not yet been elucidated. Methods: Inflammatory cytokine profiles in PB and BM of 24 Ph-MPNs patients were measured by a multiplex quantitative inflammation array. Cytokines that correlated between PB and BM were selected and then validated by ELISA in a separate cohort of 52 MPN patients. Furthermore, a panel of cytokines was identified and examined for potential application as non-invasive markers for the diagnosis and prediction of fibrosis progress of MPN subtypes. Results: The levels of G-CSF, I-309, IL-1β, IL-1ra, IL-12p40, IL-15, IL-16, M-CSF, MIG, PDGF-BB, and TIMP-1 in BM supernatants were significantly higher than those in PB (all p < 0.05). Linear correlations between BM and PB levels were found in 13 cytokines, including BLC, Eotaxin-2, I-309, sICAM-1, IL-15, M-CSF, MIP-1α, MIP-1δ, RANTES, TIMP-1, TIMP-2, sTNFRI, and sTNFRII (all R > 0.4 and p < 0.05). Levels of BLC, Eotaxin-2, M-CSF, and TIMP-1 in PB were significantly different from those in health controls (all p < 0.05). In PB, levels of TIMP-1 and Eotaxin-2 in essential thrombocythemia (ET) group were significantly lower than those in groups of prefibrotic primary myelofibrosis (pre-PMF) [TIMP-1: 685.2 (322.2–1,229) ng/ml vs. 1,369 (1,175–1,497) ng/ml, p = 0.0221; Eotaxin-2: 531.4 (317.9–756.6) pg/ml vs. 942.4 (699.3–1,474) pg/ml, p = 0.0393] and primary myelofibrosis (PMF) [TIMP-1: 685.2 (322.2–1229) ng/ml vs. 1,365 (1,115–1,681) ng/ml, p = 0.0043; Eotaxin-2: 531.4 (317.9–756.6) pg/ml vs. 1,010 (818–1,556) pg/ml, p = 0.0030]. The level of TIMP-1 in myelofibrosis (MF) >1 group was significantly higher than that in MF ≤ 1 group. Conclusion: Abnormal inflammatory status is present in MPN, especially in its BM microenvironment. Consistency between PB and BM levels was found in multiple inflammatory cytokines. Circulating cytokine levels of BLC, M-CSF, Eotaxin-2, and TIMP-1 reflected inflammation inside BM niche, suggesting potential diagnostic value for MPN subtypes and prognostic value for fibrosis progression.

Mimicry Between Neurokinin-1 and Fibronectin May Explain the Transport and Stability of Increased Substance P Immunoreactivity in Patients with Bone Marrow Fibrosis

Negative Feedback on the Effects of Stem Cell Factor on Hematopoiesis is Partly Mediated Through Neutral Endopeptidase Activity on Substance P: a Combined Functional and Proteomic Study

The Dynamics of Bone Marrow Stromal Cells in the Proliferation of Multipotent Hematopoietic Progenitors by Substance P: an Understanding of the Effects of a Neurotransmitter on the Differentiating Hematopoietic Stem Cell.

NF-kappa B As a Central Mediator in the Induction of TGF-beta in Monocytes from Patients with Idiopathic Myelofibrosis: an Inflammatory Response Beyond the Realm of Homeostasis.

Effects of Preprotachykinin‐I Peptides on Hematopoietic Homeostasis: A Role for Bone Marrow Endopeptidases

Differences in the Expression of Neurokinin Receptor in Neural and Bone Marrow Mesenchymal Cells: Implications for Neuronal Expansion from Bone Marrow Cells

Induction of Hypoxia-Inducible Factor-1Alpha and Activation of Caspase-3 in Hypoxia-Reoxygenated Bone Marrow Stroma is Negatively Regulated by the Delayed Production of Substance P.

Hematopoietic growth factor inducible neurokinin-1 type: a transmembrane protein that is similar to neurokinin 1 interacts with substance P

Effects Of Sp(1-4) On Cobblestone-Forming Cells. Implications For Endopeptidases As Hematopoietic Regulators

Increased Expression of Preprotachykinin-I and Neurokinin Receptors in Human Breast Cancer Cells: Implications for Bone Marrow Metastasis.

Substance P Induces Monocyte Chemoattractant Protein-1 Production In Skin Fibroblasts From Genetically-Diabetic Mice Via Activation Of Nf-Kappa B

Substance P and its receptors in bone metabolism.

Substance P Induces Inflammatory Responses Involving NF-κB in Genetically Diabetic Mice Skin Fibroblasts Co-Cultured with Macrophages.

Characterization of Fibroblast-Specific Protein 1 in Pulmonary Fibrosis

Identification of a fibronectin-binding protein signature associated with idiopathic pulmonary fibrosis

Cytokine Consistency Between Bone Marrow and Peripheral Blood in Patients with Philadelphia-Negative Myeloproliferative Neoplasms

Substance P Receptor Expression in Human Skin Keratinocytes and Fibroblasts.

Substance P induces fibrotic changes through activation of the RhoA/ROCK pathway in an in vitro human corneal fibrosis model

Increase in Substance P Precursor Mrna in Noninflamed Small-Bowel Sections in Patients with Crohn’s Disease

Substance P alleviates liver fibrosis by modulating inflammation and mobilizing reparative stem cells

Substance P modulates BMSCs migration for tissue repair through NK-1R/CXCR4/p-Akt signal activation